Notice Type
Notice Title

Renewal of Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Product: Replagal
Active Ingredient: Agalsidase alfa 1mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: St Ives Medical
Manufacturer: Chesapeake Biological Laboratories Inc (CBL), Camden Industrial Park, Baltimore, Maryland, United States of America
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 22nd day of August 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).